Also, they introduced the Animal health products ... Ltd into Glaxo India Limited was completed and the name of the company was changed to the present name GlaxoSmithKline Pharmaceuticals Ltd.

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 41,409.61 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the ...

The annual per capita pharmaceutical sales are less than US$32. Most of this spent is out of the pocket. By providing a big portfolio of 140 products with a relative low price, GSK is winning the ...

David Redfern, chief strategy officer, GlaxoSmithKline. India's pharmaceutical market is worth about US$12 billion, Bloomberg reported. GlaxoSmithKline Pharmaceuticals Ltd, the operation in India ...

India’s Ministry of Health has taken no steps to stop other pharmaceutical companies from continuing to manufacture and sell ...

WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the Biotechnology Innovation Organization.

Revenue 1,010.77 814.65 929.80 805.26 ...

With the pharmaceutical industry aiming to grow from $58 billion to $130 billion by 2030, he highlighted significant ...

24 Jul, 2018 11 Sep, 2018 1:1 For every 1 share held; Holder will receive 1 bonus shares. 28 Sep, 1994 02 Jan, 1995 1:1 For every 1 share held; Holder will receive 1 bonus shares. 23 Jun, 1980-1:3 ...